SE8803935L - Laekemedelskomposition - Google Patents

Laekemedelskomposition

Info

Publication number
SE8803935L
SE8803935L SE8803935A SE8803935A SE8803935L SE 8803935 L SE8803935 L SE 8803935L SE 8803935 A SE8803935 A SE 8803935A SE 8803935 A SE8803935 A SE 8803935A SE 8803935 L SE8803935 L SE 8803935L
Authority
SE
Sweden
Prior art keywords
pharmaceutical substance
composition
laekemedelskomposition
pharmaceutical
finely
Prior art date
Application number
SE8803935A
Other languages
Unknown language ( )
English (en)
Other versions
SE8803935D0 (sv
Inventor
C Nystroem
Original Assignee
Kabivitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20373813&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8803935(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kabivitrum Ab filed Critical Kabivitrum Ab
Priority to SE8803935A priority Critical patent/SE8803935L/sv
Publication of SE8803935D0 publication Critical patent/SE8803935D0/sv
Priority to DE68914683T priority patent/DE68914683T2/de
Priority to AU44808/89A priority patent/AU4480889A/en
Priority to PCT/SE1989/000599 priority patent/WO1990004962A1/en
Priority to AT89911914T priority patent/ATE104141T1/de
Priority to EP89911914A priority patent/EP0440702B1/en
Publication of SE8803935L publication Critical patent/SE8803935L/sv
Priority to SE9101027A priority patent/SE466088B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8803935A 1988-10-31 1988-10-31 Laekemedelskomposition SE8803935L (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE8803935A SE8803935L (sv) 1988-10-31 1988-10-31 Laekemedelskomposition
DE68914683T DE68914683T2 (de) 1988-10-31 1989-10-27 Arzneimittelzusammensetzung für die schnelle verabreichung des aktiven bestandteils, der aus einer festen dispersion und einem oberflächenaktiven mittel besteht.
AU44808/89A AU4480889A (en) 1988-10-31 1989-10-27 A pharmaceutical composition for rapid release of the active component comprising an orderred mixture and a surfactant
PCT/SE1989/000599 WO1990004962A1 (en) 1988-10-31 1989-10-27 A pharmaceutical composition for rapid release of the active component comprising an orderred mixture and a surfactant
AT89911914T ATE104141T1 (de) 1988-10-31 1989-10-27 Arzneimittelzusammensetzung fuer die schnelle verabreichung des aktiven bestandteils, der aus einer festen dispersion und einem oberflaechenaktiven mittel besteht.
EP89911914A EP0440702B1 (en) 1988-10-31 1989-10-27 A pharmaceutical composition for rapid release of the active component comprising a solid dispersion and a surfactant
SE9101027A SE466088B (sv) 1988-10-31 1991-04-08 Laekemedelskomposition foer snabbt frigoerande av aktiv laekemedelssubstans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8803935A SE8803935L (sv) 1988-10-31 1988-10-31 Laekemedelskomposition

Publications (2)

Publication Number Publication Date
SE8803935D0 SE8803935D0 (sv) 1988-10-31
SE8803935L true SE8803935L (sv) 1990-05-01

Family

ID=20373813

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8803935A SE8803935L (sv) 1988-10-31 1988-10-31 Laekemedelskomposition

Country Status (5)

Country Link
EP (1) EP0440702B1 (sv)
AU (1) AU4480889A (sv)
DE (1) DE68914683T2 (sv)
SE (1) SE8803935L (sv)
WO (1) WO1990004962A1 (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW402506B (en) 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
US6531158B1 (en) * 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
ES2305434T3 (es) 2002-02-01 2008-11-01 Pfizer Products Inc. Composiciones framaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas.
WO2005011635A2 (en) 2003-08-04 2005-02-10 Pfizer Products Inc. Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
GB0423800D0 (en) 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
EP1845946A2 (en) * 2005-02-10 2007-10-24 Orexo AB Pharmaceutical compositions useful in the transmucosal administration of drugs
EP1863454A2 (en) * 2005-03-28 2007-12-12 Orexo AB New pharmaceutical compositions useful in the treatment of migraine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE5852T1 (de) * 1978-11-20 1984-02-15 American Home Products Corporation Therapeutische zusammensetzungen mit gesteigerter bioverfuegbarkeit und verfahren zu deren herstellung.
US4629621A (en) * 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
WO1987000428A1 (en) * 1985-07-24 1987-01-29 Pyare Seth Oxazepam containing pharmaceutical composition

Also Published As

Publication number Publication date
DE68914683D1 (de) 1994-05-19
EP0440702A1 (en) 1991-08-14
AU4480889A (en) 1990-05-28
SE8803935D0 (sv) 1988-10-31
EP0440702B1 (en) 1994-04-13
WO1990004962A1 (en) 1990-05-17
DE68914683T2 (de) 1994-10-27

Similar Documents

Publication Publication Date Title
DE3774341D1 (de) Nikotin enthaltende tablette.
DK393187A (da) Laegemiddel med antitumorvirkning
DK588487A (da) Forbedrede metalholdige farmaceutiske midler
DE68903846T2 (de) Neue galenische form von fenofibrat.
BR8801396A (pt) Composto,mistura polimerizavel por radiacao e material de registro
DE3366494D1 (de) New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
NL300007I1 (nl) Preparaat voor de gereguleerde afgifte van een werkzame stof.
IT8721411A0 (it) Composizione farmaceutica idrosolubile contenente n acetilsisteina.
SE8803935D0 (sv) Laekemedelskomposition
IT8721410A0 (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina.
ATE138590T1 (de) Pyrogensorbentmittel
NO870397D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive organiske platinakomplekser.
NO902626L (no) Fremgangsmaate for stabilisering av biologisk aktive forbindelser immobilisert paa faste faser.
SE8800080L (sv) Laekemedelskomposition
FI791565A (fi) Farmaceutiska sammansaettningar innehaollande prostaglandinfoereningar
FI884240A (sv) Förfarande för framställning av för topiskt bruk avsedd farmaceutisk produkt
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
SG153894G (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
EP0265338A3 (en) Stable therapeutical compositions based on hydrophobic vegetable oil, and process for preparing them
ES2051953T3 (es) Derivados isomeros de trimetilbiciclo(4,3,0)nonano.
SE9101027D0 (sv) Laekemedelskomposition
ES8502611A1 (es) Un procedimiento para preparar composiciones farmaceuticas a base de sales de teofilina y aminoacidos basicos
JPS5223586A (en) Carrier for fixing physiologically active material
DE3773322D1 (de) Pharmazeutische zubereitungen mit heilender aktivitaet.
SE8503513D0 (sv) Farmaceutiska och kosmetiska kompositioner, vilka som verksam bestandsdel innehaller acetyl-10-triacetoxi-1,8,9-antracen